UBS O'Connor’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-25,203
Closed -$1.95M 553
2023
Q4
$1.95M Sell
25,203
-39,132
-61% -$2.74M 0.06% 175
2023
Q3
$4.38M Buy
64,335
+56,500
+721% +$4.11M 0.08% 142
2023
Q2
$637K Sell
7,835
-565
-7% -$45.1K 0.01% 427
2023
Q1
$689K Sell
8,400
-18,000
-68% -$1.29M 0.02% 440
2022
Q4
$1.54M Buy
+26,400
New +$1.52M 0.03% 514

Other funds holding GEHC

UBS O'Connor's GEHC Position: Q1 2024 in Review

UBS O'Connor sold out of GE HealthCare (GEHC) in Q1 2024, closing a stake of 25,203 shares — an estimated $1.95M sold.

UBS O'Connor first reported a position in GEHC in Q4 2022 and held it in 5 quarters. The position peaked at $4.38M in Q3 2023. 1,257 funds tracked by Wall St. Rank hold GEHC as of Q1 2024.

  • UBS O'Connor reported no remaining GE HealthCare position as of Q1 2024 after selling out during the quarter.
  • UBS O'Connor sold 25,203 GE HealthCare shares in Q1 2024, an estimated $1.95M.
  • UBS O'Connor first reported a position in GE HealthCare in Q4 2022 and held it in 5 quarters.
  • UBS O'Connor's GE HealthCare position peaked at $4.38M in Q3 2023.
  • 1,257 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2024.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.